1-stearoyl-2-oleoyl-sn-glycero-3-phospho-1D-myo-inositol

Metabolite details

Identifier

YOBFISPJJWPPTK-BAAZTTAESA-N

InChI Key

YOBFISPJJWPPTK-BAAZTTAESA-N

IUPAC name

(2R)-1-[(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]-3-(octadecanoyloxy)propan-2-yl (9Z)-octadec-9-enoate

Preferred name

1-stearoyl-2-oleoyl-sn-glycero-3-phospho-1D-myo-inositol

INN name

—

Synonym

1-18:0-2-18:1-phosphatidylinositol

ChEBI

CHEBI:77346

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Industrial by-products as a novel circular source of biocompatible extracellular vesicles
• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity

Observed in differential profiles

• Brewer_Spend_Yeast_vs_Whey
• Control_vs_OXPA_Treatment
• Control_vs_OXPA_Treatment
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• Control_vs_Palmitate